Expansion Opportunity goBalto has a track record of accelerating clinical trial startup times and binds with Oracle Health Sciences to offer end-to-end cloud solutions. This suggests potential upsell opportunities for larger pharma and CRO clients seeking faster site activation and streamlined startup processes within a broader cloud platform.

Cloud-Based Strength With a cloud-first approach and Oracle Cloud integration, there is a strong sales angle to position goBalto as a scalable, secure, and compliant starter for multicenter trials across 80+ countries, appealing to sponsors prioritizing digital modernization and global site management.

Global Reach Active across more than 80 countries and 2,000+ studies, goBalto demonstrates broad geographic coverage. This enables targeting multinational trial programs, especially sponsors requiring consistent startup workflows across regions.

Industry Credibility Historical recognition and media coverage, including being acquired by Oracle and prior industry awards, provide credibility to engage potential customers who value proven technology partners in clinical operations and life sciences cloud ecosystems.

Market Positioning As a mid-sized player with a clear specialty in study startup solutions, goBalto can partner with larger EHR/CTMS platforms or CROs seeking to complement their offerings with rapid site selection and startup automation, unlocking cross-sell and alliance opportunities.